RecallHawk
Class II Recall

Trevo XP ProVue Retriever 4 x 20, Catalog: 90182 Trevo XP ProVue Retriever 3 x 20, Catalog: 90183 Trevo XP ProVue Retr

Stryker Neurovascular

Summary

The FDA issued a Class II for Trevo XP ProVue Retriever 4 x 20, Catalog: 90182 Trevo XP ProVue Retriever 3 x by Stryker Neurovascular. Reason: Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance wit.

Details

Source

Device Recall

External ID

Z-1902-2024

Action Date

2024-06-05

Status

Ongoing

Category

device

Product Description

Trevo XP ProVue Retriever 4 x 20, Catalog: 90182 Trevo XP ProVue Retriever 3 x 20, Catalog: 90183 Trevo XP ProVue Retriever 4 x 30, Catalog: 90185 Trevo XP ProVue Retriever 6 x 25, Catalog: 90186 Kits: TREVO XP 3X20+PRO14 2-PACK, Catalog: 80051 TREVO XP 4X20+PRO18 2-PACK, Catalog: 80052 TREVO XP 4X30+PRO18 2-PACK, Catalog: 93067 TREVO XP 6X25+XT27 2-PACK, Catalog: 93068 TREVO XP 3X20+PRO14+CAT6 3-PACK - CE, Catalog: M0033PK32021002 TREVO XP 4X20+PRO18+CAT6 3-PACK - CE, Catalog: M0033PK42022002 TREVO XP 6X25+XT27+CAT6 3-PACK - CE, Catalog: M0033PK62523002

Lot/Code Info: Catalog/UDI-DI/Lot: 90182/00815742001822/116706; 90183/00815742001839/117514; 90185/00815742001853/118900; 90186/00815742001860/114054; 80051/00815742000511/47307561, 47328877, 47351811, 47398058, 47398074, 48521577, 48521585, 48540280, 48540281, 48540282, 48540283, 48540284, 48556786, 48588490, 48607589, 48676218, 48696629, 48715720, 48736116, 48736122, 48754915, 48754920, 48772012, 48772014, 48772025, 50065499, 50065511, 50065512, 50065513, 50065514, 50065515, 50065518, 50113384, 50113385, 50133176, 50133191, 50193582, 50216273, 50216274, 50216277, 50239676, 50260575, 50260583, 50280979, 50281011, 50304688, 50304712, 50304713, 50304714, 50397877, 50422572, 50422582, 50422589, 50448279, 50519274, 50519275, 50519276, 50519277, 50519285, 50519295, 50577572, 50607374, 50607376, 50607377, 50607378, 50650278, 50650279, 50650288, 50673881, 50673884, 50673908, 50673909, 50673910, 50673911, 50673930, 50694279, 50738912, 50786710, 50850697, 50869887, 50869892, 50869905, 50886487, 50912493, 50912514, 50912515, 50912516, 50912517, 50931490, 50931518, 50931519, 50950402, 50967093, 51320497, 51350503, 51350505, 51489228, 51489235, 51513311, 51513516, 51535421, 51729133; 80052/00815742000528/49021114, 49021115, 49021116, 49021117, 49021118, 49033114, 49033115, 49033116, 49033117, 49052517, 49052525, 49192125, 49192140, 49192141, 49216723, 49216724, 49216737, 53175402; 93067/00815742000672/53320201; 93068/00815742000689/48963313, 49056315, 49155966, 49216725, 49318831, 49318836, 49318837, 49418740, 49418743, 49441346, 50000932, 50000933, 50000934, 50029333, 50029340, 50029361, 50047054, 50065482, 50065485, 50065486, 50065487; M0033PK32021002/07613327126334/48500990, 48624226, 48641523, 48641533, 50156372, 50519272, 50650290, 50912513, 50967091; M0033PK42022002/07613327126358/48995917, 49033123, 49140624, 49236926; M0033PK62523002/07613327126365/49033118, 49236935, 50047053

Quantity Affected: 461

Reason for Recall

Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.

Distribution

Worldwide - US Nationwide distribution including in the states of MN, PA, IL, AK, NY, CA, MI, WI, TX, AZ, FL, KY, MA, IN, NE, MT, CT, NJ, TN, VA, AL, CO, DE, OH, UT, NC, ME, GA, SC, GU, WA, MO, OR, DC, OK, LA, MD, ID, NH, SD, NV, RI, ND, HI, MS, AR, IA, NM, VT, KS and the countries of Australia, Austria, Belgium, Brazil, Canada, Canary Islands, Chile, China, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, SAR China, Hungary, India, Ireland, Israel, Italy, Japan, Korea (South), Lithuania, Luxembourg, Netherlands, Northern Ireland, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland, Taiwan, Republic of China, Thailand, Turkey, United Arab Emirates, United Kingdom.

Type: Voluntary: Firm initiated

Recall Initiated: 2024-04-23

Company

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 258 device recalls issued in the same week, part of 403 device-related FDA actions this month.

Stryker Neurovascular has 26 FDA actions in our database, including 14 recalls and 12 clearances.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Stryker Neurovascular) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Stryker Neurovascular have FDA actions?

Stryker Neurovascular has 26 FDA actions in our database, including 14 recalls and 12 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-1902-2024" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions